Compare Liquidia Corporation Common Stock (LQDA) vs Newmont Corporation (NEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Liquidia Corporation Common Stock vs Newmont Corporation — how do they compare? Liquidia Corporation Common Stock trades at $33.9 (market cap $3.04B), while Newmont Corporation trades at $112.72 (market cap $117.55B). The key difference: Newmont Corporation is far larger — about 38.7× Liquidia Corporation Common Stock's market cap, and Newmont Corporation pays a 0.93% dividend while Liquidia Corporation Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Liquidia Corporation Common Stock for 0 Days and Newmont Corporation for 59 Days on average.
| LQDA | NEM | |
|---|---|---|
Market Cap | $3.04B | $117.55B |
Volume | 21,111,778 | 6,644,300 |
Sector | Health | Basic Materials |
52-Week High | $91.03 | $135.14 |
52-Week Low | $22.02 | $78.63 |
Typical Hold Time | 0 Days | 59 Days |
Enterprise Value | $2.94B | $114.14B |
Dividend Yield | — | 0.93% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
NEM (Newmont Corporation) trades at $115.59, down 1.33% on the day, with a bullish technical signal and strong fundamental momentum. The stock has consistently beaten earnings estimates, with Q1 2026 EPS of $2.90 surpassing the $2.07 forecast. Revenue surged to $22.67 billion in 2025, driving a net income margin of 31.25%. Analyst consensus is strongly bullish, with 28 buys and a $136.83 price target, supported by record free cash flow of $5.3 billion in H1 2026 (Defense World, 2026-10-01).
The outlook remains positive given operational improvements and supportive gold prices, though risks include gold price volatility and execution of growth projects. Upside potential exists if the company maintains its earnings beat streak and converts strong cash flow into per-share value, as highlighted by management (MarketBeat, 2026-09-29).
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Liquidia Corporation Common Stock
Liquidia Corporation is a biopharmaceutical company that develops therapies for rare cardiopulmonary diseases, including YUTREPIA, an inhaled treprostinil powder for pulmonary hypertension built on its PRINT technology.
Read more on LQDA →About Newmont Corporation
Newmont Corp is primarily a gold producer with operations and/or assets in the United States, Canada, Mexico, Dominican Republic, Peru, Suriname, Argentina, Chile, Australia, and Ghana. It is also engaged in the production of copper, silver, lead and zinc. The company's operations are organized in five geographic regions: North America, South America, Australia, Africa and Nevada.
Read more on NEM →
